1-2 of 2
Bo Pei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTA311, a universal anti-CD19 CAR t-cell therapy with improved persistence for patients with CD19+ relapsed/ refractory (R/R) b-cell acute lymphoblastic leukemia (B-ALL)

Free
Guangyu Sun, Heng Mei, Anyou Wang, Tianzhong Pan, Yali Zhou, Gong Chen, Jiuqin Zeng, Kangqi Bian, Jan Davidson-Moncada, Bo Pei, Lu Han, Jiangtao Ren, Xiaoyu Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5920.
https://doi.org/10.1182/blood-2025-5920
Published: 2025
Journal Articles

A Novel Universal CD7-Targeted CAR-T Cell Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma

Free
Xian Zhang, Yali Zhou, Junfang Yang, Jingjing Li, Liyuan Qiu, Wengang Ge, Bo Pei, Jie Chen, Lu Han, Jiangtao Ren, Peihua Lu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4566–4567.
https://doi.org/10.1182/blood-2022-165733
Published: 2022